News / Taiwan / economic_daily
Pei-E Biomedical to Split Stock 1-for-20, Resuming Trading September 7
Health Technology · Biotechnology · economic_daily · 2026-08-26
6949
Pei-E Biomedical is set to undergo a 1-for-20 stock split, adjusting its par value from NT$10 to NT$0.5, with trading resuming on September 7.
What Happened
Stock Split Details: Pei-E Biomedical has received regulatory approval to change its par value per share from NT$10 to NT$0.5, effectively executing a 1-for-20 stock split. The company will suspend trading from August 27 to September 4 to facilitate the change, with new shares scheduled to begin trading on September 7.
Market Performance: The company's stock has seen significant gains, recently surpassing the NT$1,000 threshold and hitting a record high of NT$1,490 on August 26. Analysts attribute this surge to both the company's focus on CAR-T regenerative medicine and a highly concentrated shareholding structure.
Shareholder Concentration: Institutional investors noted that over 70% of the company's shares are held by directors, supervisors, and major stakeholders. This tight control over the float has contributed to the stock's recent upward momentum and volatility.
Strategic Outlook: Following the completion of the share split, the company is expected to continue its development in the regenerative medicine sector. Market participants are advised to monitor the stock's liquidity and price action once trading resumes in September.